Increased fracture rate in women with breast cancer: a review of the hidden risk

por Body, Jean-Jacques
Publicado 2011

Hypercalcaemia and hypocalcaemia: finding the balance

por Body, Jean-Jacques, Niepel, Daniela, Tonini, Giuseppe
Publicado 2017

Hypocalcaemia in patients with prostate cancer treated with a bisphosphonate or denosumab: prevention supports treatment completion

por Body, Jean-Jacques, von Moos, Roger, Niepel, Daniela, Tombal, Bertrand
Publicado 2018

Additive growth inhibitory effects of ibandronate and antiestrogens in estrogen receptor-positive breast cancer cell lines

por Journe, Fabrice, Chaboteaux, Carole, Magne, Nicolas, Duvillier, Hugues, Laurent, Guy, Body, Jean-Jacques
Publicado 2006

Extracellular calcium increases bisphosphonate-induced growth inhibition of breast cancer cells

por Journé, Fabrice, Kheddoumi, Naïma, Chaboteaux, Carole, Duvillier, Hugues, Laurent, Guy, Body, Jean-Jacques
Publicado 2008

Breast cancer patients with bone metastases are characterised by increased levels of nonisomerised type I collagen fragments

por Andreas Compare Cloos, Paul, Christgau, Stephan, Lyubimova, Nina, Body, Jean-Jacques, Qvist, Per, Christiansen, Claus
Publicado 2003

Updated guidance on the management of cancer treatment-induced bone loss (CTIBL) in pre- and postmenopausal women with early-stage breast cancer

por Waqas, Komal, Lima Ferreira, Joana, Tsourdi, Elena, Body, Jean-Jacques, Hadji, Peyman, Zillikens, M.C.
Publicado 2021

The Src inhibitor dasatinib accelerates the differentiation of human bone marrow-derived mesenchymal stromal cells into osteoblasts

por Id Boufker, Hichame, Lagneaux, Laurence, Najar, Mehdi, Piccart, Martine, Ghanem, Ghanem, Body, Jean-Jacques, Journé, Fabrice
Publicado 2010

A real-world study assessing the use of bone-targeted agents and their impact on bone metastases in patients with prostate cancer treated in clinical practice in Europe

por Body, Jean-Jacques, von Moos, Roger, Rider, Alex, Hallworth, Pamela, Bhowmik, Debajyoti, Gatta, Francesca, Hechmati, Guy, Qian, Yi
Publicado 2018

Bone-targeted agent treatment patterns and the impact of bone metastases on patients with advanced breast cancer in real-world practice in six European countries

por von Moos, Roger, Body, Jean-Jacques, Rider, Alex, de Courcy, Jonathan, Bhowmik, Debajyoti, Gatta, Francesca, Hechmati, Guy, Qian, Yi
Publicado 2017

Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS

por Anastasilakis, Athanasios D, Pepe, Jessica, Napoli, Nicola, Palermo, Andrea, Magopoulos, Christos, Khan, Aliya A, Zillikens, M Carola, Body, Jean-Jacques
Publicado 2021

Response to Letter to the Editor From Taguchi: “Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS”

por Anastasilakis, Athanasios D, Pepe, Jessica, Napoli, Nicola, Palermo, Andrea, Magopoulos, Christos, Khan, Aliya A, Zillikens, M Carola, Body, Jean-Jacques
Publicado 2022

Health state utilities for skeletal-related events secondary to bone metastases

por Matza, Louis S., Chung, Karen, Van Brunt, Kate, Brazier, John E., Braun, Ada, Currie, Brooke, Palsgrove, Andrew, Davies, Evan, Body, Jean-Jacques
Publicado 2013

Physicians’ preferences for bone metastases treatments in France, Germany and the United Kingdom

por Qian, Yi, Arellano, Jorge, Gatta, Francesca, Hechmati, Guy, Hauber, A. Brett, Mohamed, Ateesha F., Bahl, Amit, von Moos, Roger, Body, Jean-Jacques
Publicado 2018

Prevention and Treatment of Glucocorticoid-Induced Osteoporosis in Adults: Consensus Recommendations From the Belgian Bone Club

por Laurent, Michaël R., Goemaere, Stefan, Verroken, Charlotte, Bergmann, Pierre, Body, Jean-Jacques, Bruyère, Olivier, Cavalier, Etienne, Rozenberg, Serge, Lapauw, Bruno, Gielen, Evelien
Publicado 2022

Tumor-Induced Osteomalacia: A Systematic Clinical Review of 895 Cases

por Bosman, Ariadne, Palermo, Andrea, Vanderhulst, Julien, De Beur, Suzanne M. Jan, Fukumoto, Seiji, Minisola, Salvatore, Xia, Weibo, Body, Jean-Jacques, Zillikens, M. Carola
Publicado 2022

Patients’ preferences for bone metastases treatments in France, Germany and the United Kingdom

por Hechmati, Guy, Hauber, A. Brett, Arellano, Jorge, Mohamed, Ateesha F., Qian, Yi, Gatta, Francesca, Haynes, Ian, Bahl, Amit, von Moos, Roger, Body, Jean-Jacques
Publicado 2014

Pathologic fracture and healthcare resource utilisation: A retrospective study in eight European countries

por Body, Jean-Jacques, Acklin, Yves Pascal, Gunther, Oliver, Hechmati, Guy, Pereira, João, Maniadakis, Nikos, Terpos, Evangelos, Finek, Jindrich, von Moos, Roger, Talbot, Susan, Sleeboom, Harm
Publicado 2016

Healthcare-resource utilization associated with radiation to bone across eight European countries: Results from a retrospective study

por von Moos, Roger, Body, Jean-Jacques, Guenther, Oliver, Terpos, Evangelos, Acklin, Yves Pascal, Finek, Jindrich, Pereira, João, Maniadakis, Nikos, Hechmati, Guy, Talbot, Susan, Sleeboom, Harm
Publicado 2018

An observational time and motion study of denosumab subcutaneous injection and zoledronic acid intravenous infusion in patients with metastatic bone disease: results from three Eur...

por Body, Jean-Jacques, Gatta, Francesca, De Cock, Erwin, Tao, Sunning, Kritikou, Persefoni, Wimberger, Pauline, Mebis, Jeroen, Peeters, Marc, Pedrazzoli, Paolo, Caraceni, Augusto, Adamo, Vincenzo, Hechmati, Guy
Publicado 2017